Related Experiment Videos
Cardiac sarcoidosis: from early recognition to management
Wilfred Ifeanyi Umeojiako1, Vasileios Kouranos2, Rakesh Sharma2
1Royal Brompton and Harefield Hospitals, part of Guy's and St Thomas' NHS Foundation Trust, UK.
Current Opinion in Immunology
|July 27, 2026
Summary
Cardiac sarcoidosis (CS) is a serious heart condition that can be hard to diagnose. This review synthesizes evidence on diagnosing and managing CS, focusing on immunosuppression and advanced heart failure treatments.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Cardiac sarcoidosis (CS) is an inflammatory condition primarily affecting myocardial tissues.
- It often presents insidiously, with variable clinical manifestations including arrhythmias and heart failure.
- Diagnosis is challenging due to its enigmatic presentation and association with extra-cardiac structures.
Purpose of the Study:
- To review and synthesize current evidence on the diagnosis of cardiac sarcoidosis.
- To outline current management strategies for cardiac sarcoidosis.
- To highlight the importance of a multidisciplinary approach in CS.
Main Methods:
- Literature review of existing evidence.
- Synthesis of diagnostic criteria and risk stratification tools.
- Summary of therapeutic interventions including immunosuppression and advanced therapies.
Main Results:
- Cardiac sarcoidosis diagnosis is complex, requiring a multidisciplinary approach.
- Treatment involves immunosuppression, guideline-directed medical therapy, device therapy, and heart transplantation.
- Early diagnosis and risk stratification are crucial for effective management.
Conclusions:
- Cardiac sarcoidosis requires a comprehensive diagnostic and management strategy.
- Multidisciplinary care is essential for optimizing patient outcomes.
- Further research is needed to refine diagnostic and therapeutic approaches.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...